Clinical Trial Update: Autologous and Allogeneic Transplant for Relapsed Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on autologous and allogeneic transplant for relapsed lymphoma, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Columbia University | Conditions: Non-Hodgkin's Lymphoma, Hodgkins Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-27